#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine carcinoma of the skin Antisynthetase syndrome Polyneuropathy Renal cell carcinoma Toxic epidermal necrolysis Vulval cancer recurrent Thrombocytopenia Lung adenocarcinoma Retinitis pigmentosa Cryoglobulinaemia Methylmalonic acidaemia Systemic candida Cutaneous lupus erythematosus Infertility female Breast angiosarcoma More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Life with Disease Systemic mastocytosis – Treatment Nephroblastoma – Trials in Disease Angiosarcoma recurrent – Life with Disease Proteus syndrome Glomerulonephritis membranoproliferative – Treatment Alveolar rhabdomyosarcoma – Basic Information Familial haemophagocytic lymphohistiocytosis – Treatment Immunodeficiency congenital – Treatment Retinitis pigmentosa – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triheptanoin Mirtazapine Tenofovir Disoproxil Durvalumab Tucidinostat Propranolol Hydrochloride Imiquimod Sodium Iodide (123 I) Chlorhexidine Gluconate Doconexent Tislelizumab Giredestrant Sodium Lithium Sulphate, Anhydrous Sodium Nitroprusside Dihydrate Patiromer Mbf-015 Etoposide Idelalisib Goserelin Acetate More therapies…

    Learn about Your Condition

    Peritoneal dialysis Metastases to biliary tract Pulmonary fibrosis Liver transplant rejection Chronic hepatitis C Type IIa hyperlipidaemia Tachypnoea Renal impairment Leukaemia Delayed graft function Psychogenic seizure Acute kidney injury Mastocytosis Autoimmune uveitis Rett syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    Investigated Drugs:
    • Nivolumab
    Italy Poland Spain

  • Study on the Safety and Effectiveness of CTX001 for Children with Severe Sickle Cell Disease Using Exagamglogene Autotemcel, Busulfan, and Plerixafor

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Exagamglogene Autotemcel
    • Plerixafor
    • Busulfan
    Germany Italy

  • Study on Managing Risk Factors in Patients with Unruptured Brain Aneurysms Using Carbasalate Calcium and Intensive Blood Pressure Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Intracranial aneurysm
    Investigated Drugs:
    • Dipyridamole
    • Acetylsalicylic Acid
    Finland Germany The Netherlands

  • Study of DDCART-CD19 cells with cyclophosphamide and fludarabine for children and young adults (up to 39 years) with recurrent acute leukemia after stem cell transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    Investigated Drugs:
    • Ddcart‐Cd19
    • Cyclophosphamide
    • Fludarabine Phosphate
    Greece

  • Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Lisdexamfetamine Dimesylate
    • Methylphenidate Hydrochloride
    Poland

  • Study on the Effects of Rivaroxaban in Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Rivaroxaban
    The Netherlands
Previous Page
1 … 308 309 310 311 312 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!